These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18829531)

  • 1. Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.
    Zheng J; Koblinski JE; Dutson LV; Feeney YB; Clevenger CV
    Cancer Res; 2008 Oct; 68(19):7769-78. PubMed ID: 18829531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New mechanisms for PRLr action in breast cancer.
    Clevenger CV; Gadd SL; Zheng J
    Trends Endocrinol Metab; 2009 Jul; 20(5):223-9. PubMed ID: 19535262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel and functional interaction between cyclophilin A and prolactin receptor.
    Syed F; Rycyzyn MA; Westgate L; Clevenger CV
    Endocrine; 2003; 20(1-2):83-90. PubMed ID: 12668872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity.
    Hong F; Lee J; Piao YJ; Jae YK; Kim YJ; Oh C; Seo JS; Yun YS; Yang CW; Ha J; Kim SS
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1073-80. PubMed ID: 15044094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
    Nouhi Z; Chughtai N; Hartley S; Cocolakis E; Lebrun JJ; Ali S
    Cancer Res; 2006 Feb; 66(3):1824-32. PubMed ID: 16452244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the Activity of Cyclophilin A Impedes Prolactin Receptor-Mediated Signaling, Mammary Tumorigenesis, and Metastases.
    Hakim S; Craig JM; Koblinski JE; Clevenger CV
    iScience; 2020 Oct; 23(10):101581. PubMed ID: 33083747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal.
    Yang H; Chen J; Yang J; Qiao S; Zhao S; Yu L
    Biochem Biophys Res Commun; 2007 Sep; 361(3):763-7. PubMed ID: 17678621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.
    Lee J
    Arch Pharm Res; 2010 Sep; 33(9):1401-9. PubMed ID: 20945139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin-mediated inhibition of 20alpha-hydroxysteroid dehydrogenase gene expression and the tyrosine kinase system.
    Zhong L; Parmer TG; Robertson MC; Gibori G
    Biochem Biophys Res Commun; 1997 Jun; 235(3):587-92. PubMed ID: 9207201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
    Li H; Ahonen TJ; Alanen K; Xie J; LeBaron MJ; Pretlow TG; Ealley EL; Zhang Y; Nurmi M; Singh B; Martikainen PM; Nevalainen MT
    Cancer Res; 2004 Jul; 64(14):4774-82. PubMed ID: 15256446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Aspergillus niger cypA gene encodes a cyclophilin that mediates sensitivity to the immunosuppressant cyclosporin A.
    Derkx PM; Madrid SM
    Mol Genet Genomics; 2001 Dec; 266(4):527-36. PubMed ID: 11810223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and refolding in vitro of a recombinant human cyclophilin A mutant: effect of a single Pro/Ser substitution on cyclophilin A structure and properties.
    Xu LR; Yan X; Luo M; Guan YX; Yao SJ
    Biotechnol Prog; 2008; 24(2):302-10. PubMed ID: 18333624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
    Llovera M; Pichard C; Bernichtein S; Jeay S; Touraine P; Kelly PA; Goffin V
    Oncogene; 2000 Sep; 19(41):4695-705. PubMed ID: 11032019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2.
    Jiang K; He B; Lai L; Chen Q; Liu Y; Guo Q; Wang Q
    Int J Mol Med; 2012 Aug; 30(2):302-8. PubMed ID: 22580449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity.
    Hong F; Lee J; Song JW; Lee SJ; Ahn H; Cho JJ; Ha J; Kim SS
    FASEB J; 2002 Oct; 16(12):1633-5. PubMed ID: 12207006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
    Sakamoto K; Triplett AA; Schuler LA; Wagner KU
    Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.